Modulatory Effect of Dihydromyricetin on Chronic Alcoholic Liver Injury Based on the FXR-NLRP3 Signaling Pathway and Serum and Liver Metabolomics.

MLA

Wang, Hao, et al. “Modulatory Effect of Dihydromyricetin on Chronic Alcoholic Liver Injury Based on the FXR-NLRP3 Signaling Pathway and Serum and Liver Metabolomics.” Natural Product Communications, vol. 19, no. 5, May 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1177/1934578X241250254.

APA

Wang, H., Zhou, J., Shi, W., Shao, S., & Chen, Y. (2024). Modulatory Effect of Dihydromyricetin on Chronic Alcoholic Liver Injury Based on the FXR-NLRP3 Signaling Pathway and Serum and Liver Metabolomics. Natural Product Communications, 19(5), 1–19. https://doi.org/10.1177/1934578X241250254

Chicago

Wang, Hao, Jinhang Zhou, Wenxin Shi, Shijuan Shao, and Yunzhong Chen. 2024. “Modulatory Effect of Dihydromyricetin on Chronic Alcoholic Liver Injury Based on the FXR-NLRP3 Signaling Pathway and Serum and Liver Metabolomics.” Natural Product Communications 19 (5): 1–19. doi:10.1177/1934578X241250254.